The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer’s disease: Evidence of ferroptosis
Open accessAbstract
Iron dyshomeostasis is implicated in Alzheimer’s disease (AD) alongside β-amyloid and tau pathologies. Despite the recent discovery of ferroptosis, an iron-dependent form cell death, hitherto, in vivo evidence of ferroptosis in AD is lacking. The present study uniquely adopts an integrated multi-disciplinary approach, combining protein (Western blot) and elemental analysis (total reflection X-ray fluorescence) with metabolomics (1H nuclear magnetic resonance spectroscopy) to identify iron dyshomeostasis and ferroptosis, and possible novel interactions with metabolic dysfunction in age-matched male cognitively normal (CN) and AD post-mortem brain tissue (n = 7/group). Statistical analysis was used to compute differences between CN and AD, and to examine associations between proteins, elements and/or metabolites. Iron dyshomeostasis with elevated levels of ferritin, in the absence of increased elemental iron, was observed in AD. Moreover, AD was characterised by enhanced expression of the light-chain subunit of the cystine/glutamate transporter (xCT) and lipid peroxidation, reminiscent of ferroptosis, alongside an augmented excitatory glutamate to inhibitory GABA ratio. Protein, element and metabolite associations also greatly differed between CN and AD suggesting widespread metabolic dysregulation in AD. We demonstrate iron dyshomeostasis, upregulated xCT (impaired glutathione metabolism) and lipid peroxidation in AD, suggesting anti-ferroptotic therapies may be efficacious in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Kagan, V. E., Mao, G., Qu, F., Angeli, J. P. F., Doll, S., Croix, C. S., Dar, H. H., Liu, B., Tyurin, V. A., Ritov, V. B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2238 · Cited by 3,029
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., & Stockwell, B. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603244113 · Cited by 2,329
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069 · cited 1×
“Interestingly, glutaminolysis has been shown to regulate ferroptosis alongside transferrin [53].”
BackgroundThe role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
The physiological role of zinc as an antioxidant
Bray, T. M., & Bettger, W. J. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90076-u · Cited by 892
Ferroptosis, a new form of cell death, and its relationships with tumourous diseases
Yu, H., Guo, P., Xie, X., Wang, Y., & Chen, G. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13008 · Cited by 710
Conrad, M., & Sato, H. (2012) · Amino Acids · doi:10.1007/s00726-011-0867-5 · Cited by 598
Castegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581
Williams, T. I., Lynn, B. C., Markesbery, W. R., & Lovell, M. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.004 · Cited by 392
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
Ayton, S., Wang, Y., Diouf, I., Schneider, J. A., Brockman, J., Morris, M. C., & Bush, A. I. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0375-7 · Cited by 365
Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N. P., Arredondo, M., González‐Billault, C., & Núñez, M. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12244 · Cited by 364
Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease
Mandal, P. K., Saharan, S., Tripathi, M., & Murari, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.005 · Cited by 336
Dixon, S. J. (2017) · Immunological Reviews · doi:10.1111/imr.12533 · Cited by 314
Quintana, C., Bellefqih, S., Laval, J. Y., Guerquin-Kern, J. L., Wu, T. D., Avila, J., Ferrer, I., Arranz, R., & Patiño, C. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.11.001 · Cited by 297
Ferritinophagy/ferroptosis: Iron‐related newcomers in human diseases
Tang, M., Chen, Z., Wu, D., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26954 · Cited by 290
Zinc Deficiency Causes Oxidative Damage to Proteins, Lipids and DNA in Rat Testes
Oteiza, P. I., Olin, K. L., Fraga, C. G., & Keen, C. L. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.4.823 · Cited by 289
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271
Brewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Sui, S., Zhang, J., Xu, S., Wang, Q., Wang, P., & Pang, D. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1564-7 · Cited by 221
Alzheimer disease and aducanumab: adjusting our approach
Selkoe, D. J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0205-1 · Cited by 208 · cited 1×
“tenuating brain amyloid levels have failed to halt AD progression [4] suggesting other factors at play.”
BackgroundAlterations in metabolic pathways and networks in Alzheimer’s disease
Kaddurah-Daouk, R., Zhu, H., Sharma, S., Bogdanov, M., Rozen, S. G., Matson, W., Oki, N. O., Motsinger-Reif, A. A., Churchill, E., Lei, Z., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.18 · Cited by 205
Raha, A. A., Vaishnav, R. A., Friedland, R. P., Bomford, A., & Raha-Chowdhury, R. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-55 · Cited by 177
Lewerenz, J., & Maher, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807325200 · Cited by 174
Hepcidin Is Involved in Iron Regulation in the Ischemic Brain
Ding, H., Yan, C.-Z., Shi, H., Zhao, Y.-S., Chang, S.-Y., Yu, P., Wu, W.-S., Zhao, C.-Y., Chang, Y.-Z., & Duan, X.-L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025324 · Cited by 170
Xu, J., Begley, P., Church, S. J., Patassini, S., Hollywood, K. A., Jüllig, M., Curtis, M. A., Waldvogel, H. J., Faull, R. L. M., Unwin, R. D., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.03.001 · Cited by 163
Vidal, R., Ghetti, B., Takao, M., Brefel-Courbon, C., Uro-Coste, E., Glazier, B. S., Siani, V., Benson, M. D., Calvas, P., Miravalle, L., et al. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.363 · Cited by 160
Deregulation of purine metabolism in Alzheimer's disease
Ansoleaga, B., Jové, M., Schlüter, A., Garcia-Esparcia, P., Moreno, J., Pujol, A., Pamplona, R., Portero-Otín, M., & Ferrer, I. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.004 · Cited by 159
Ashraf, A., Clark, M., & So, P.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00065 · Cited by 158
Self-citationDerry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A.-L., & Kent, T. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101716 · Cited by 153
Metabolomic changes in autopsy‐confirmed Alzheimer's disease
Kaddurah‐Daouk, R., Rozen, S., Matson, W. R., Han, X., Hulette, C. M., Burke, J. R., Doraiswamy, P. M., & Welsh-Bohmer, K. A. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.001 · Cited by 149
The Role of Zinc in Alzheimer′s Disease
Watt, N. T., Whitehouse, I. J., & Hooper, N. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/971021 · Cited by 148
Brain iron homeostasis and neurodegenerative disease
Benarroch, E. E. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a26b30 · Cited by 143
Killion, E. A., Reeves, A. R., ElAzzouny, M. A., Yan, Q.-W., Surujon, D., Griffin, J. D., Bowman, T. A., Wang, C., Matthan, N. R., Klett, E. L., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.012 · Cited by 139
In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI
Bartzokis, G., Sultzer, D. L., Mintz, J., Holt, L. E., Marx, P., Phelan, C., & Marder, S. R. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90047-7 · Cited by 136
Qin, S., Colin, C., Hinners, I., Gervais, A., Cheret, C., & Mallat, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5186-05.2006 · Cited by 135
Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage
Soria, F. N., Pérez‐Samartín, A., Martín, A., Gona, K. B., Llop, J., Szczupak, B., Chara, J. C., Matute, C., & Domercq, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71886 · Cited by 130
Braissant, O., Henry, H., Villard, A.-M., Speer, O., Wallimann, T., & Bachmann, C. (2005) · BMC Developmental Biology · doi:10.1186/1471-213x-5-9 · Cited by 128
Graham, S. F., Chevallier, O. P., Roberts, D. P. T., Hölscher, C., Elliott, C. T., & Green, B. D. (2012) · Analytical Chemistry · doi:10.1021/ac303163f · Cited by 115
Ammonia as a Potential Neurotoxic Factor in Alzheimer's Disease
Adlimoghaddam, A., Sabbir, M. G., & Albensi, B. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00057 · Cited by 110
Schallier, A., Smolders, I., Van Dam, D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., & Massie, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101005 · Cited by 109
Glutamine Acts as a Neuroprotectant against DNA Damage, Beta-Amyloid and H2O2-Induced Stress
Chen, J., & Herrup, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033177 · Cited by 105
Release of glutamate and GABA in the hippocampus under zinc deficiency
Takeda, A., Hirate, M., Tamano, H., & Oku, N. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10600 · Cited by 102
Alonso‐Andrés, P., Albasanz, J. L., Ferrer, I., & Martín, M. (2018) · Brain Pathology · doi:10.1111/bpa.12592 · Cited by 101
Kosenko, E. A., Kaminsky, Y., Lopata, O., Muravyov, N., Kaminsky, A., Hermenegildo, C., & Felipo, V. (1998) · Metabolic Brain Disease · doi:10.1023/a:1020626928259 · Cited by 96
Alzheimer’s disease and total plasma aminothiols
McCaddon, A., Hudson, P. R., Hill, D., Barber, J., Lloyd, A., Davies, G. K., & Regland, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01451-8 · Cited by 89
Antharam, V., Collingwood, J. F., Bullivant, J.-P., Davidson, M. R., Chandra, S., Mikhaylova, A., Finnegan, M. E., Batich, C., Forder, J. R., & Dobson, J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.019 · Cited by 82 · cited 1×
“Previously, brain iron was reported to both accumulate in AD [6,23] and to be unaltered [24].”
BackgroundNuttall, J. R., & Oteiza, P. I. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0379-x · Cited by 79
Braissant, O. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.02.011 · Cited by 74
Ashraf, A., Michaelides, C., Walker, T. A., Ekonomou, A., Suessmilch, M., Sriskanthanathan, A., Abraha, S., Parkes, A., Parkes, H. G., Geraki, K., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00351 · Cited by 69
Self-citationLalande-Martin, J., Halley, H., Balayssac, S., Gilard, V., Dejean, S., Martino, R., Francès, B., Lassalle, J., & Malet‐Martino, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130023 · Cited by 65
Webster, J. M., Morton, C. A., Johnson, B. F., Yang, H., Rishel, M. J., Lee, B. D., Miao, Q., Chittari, P., Yapp, D. T. T., & Schaffer, P. C. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.126664 · Cited by 57
Correa, F., Ljunggren, E., Mallard, C. E., Nilsson, M., Weber, S. G., & Sandberg, M. (2011) · Glia · doi:10.1002/glia.21151 · Cited by 49
Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease
Ashraf, A., Stosnach, H., Parkes, H. G., Hye, A., Powell, J. F., So, P., Soinine, H., Tsolaki, M., Vellas, B. J., Lovestone, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37431-8 · Cited by 39
Self-citationRegional iron distribution and soluble ferroprotein profiles in the healthy human brain
McAllum, E. J., Hare, D. J., Volitakis, I., McLean, C., Bush, A. I., Finkelstein, D. I., & Roberts, B. R. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101744 · Cited by 39
Walker, T. A., Michaelides, C., Ekonomou, A., Geraki, K., Parkes, H. G., Suessmilch, M., Herlihy, A. H., Crum, W. R., & So, P. (2016) · Aging · doi:10.18632/aging.101069 · Cited by 37
Self-citationHilgier, W., Fręśko, I., Klemenska, E., Berȩsewicz, A., Oja, S. S., Saransaari, P., Albrecht, J., & Zielińska, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.04.004 · Cited by 23
Hilgier, W., Węgrzynowicz, M., Ma̧czewski, M., Berȩsewicz, A., Oja, S. S., Saransaari, P., & Albrecht, J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9455-1 · Cited by 12
Ashraf, A., Guillen, J. A. A., Aljuhani, M., Hubens, C. J., & So, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00181 · Cited by 12
Self-citation
Cited by
The Metabolic Underpinnings of Ferroptosis
Zheng, J., & Conrad, M. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.011 · Cited by 1,329
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment
Liu, Y., Wan, Y., Jiang, Y., Zhang, L., & Cheng, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188890 · Cited by 528
Characteristics and Biomarkers of Ferroptosis
Chen, X., Comish, P. B., Tang, D., & Kang, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.637162 · Cited by 504
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Metadata
- Authors
- Ashraf, A., Jeandriens, J., Parkes, H. G., & So, P.-W.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 32
- Pages
- 101494
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W3010188616
- Cited by
- 300
- References
- 66
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.